Literature DB >> 11371002

Subtle differences in the discriminative stimulus effects of cocaine and GBR-12909.

S R Tella1, S R Goldberg.   

Abstract

1. In addition to inhibiting the dopamine transporter, cocaine affects a variety of other neurotransmitter systems. In the present study, the involvement of both dopaminergic and the nondopaminergic systems in the behavioral effects of cocaine was studied using an intravenous drug discrimination procedure. 2. One group (Group 1) of rats were trained to discriminate cocaine (1 mg/kg, i.v.) from saline, while a second group (Group 2) of rats were trained to discriminate the same dose of cocaine from both GBR-12909 (1 mg/kg i.v.), a dopamine-selective uptake inhibitor, and saline. 3. Following training, substitution tests with different doses of cocaine and several drugs pharmacologically related to cocaine were conducted. When cocaine dose was varied, there was a dose-dependent generalization to the cocaine-training stimulus in both groups of rats. Conversely, GBR-12909 and GBR-12935, another dopamine-selective uptake inhibitor, generalized to the cocaine-training stimulus in Group 1, but there was minimal or no generalization in Group 2 4. The norepinephrine-selective uptake inhibitors, desipramine and nisoxetine, and the serotonin-selective uptake inhibitor, zimeldine, produced little or no generalization to the cocaine-training stimulus in either group of rats. The sodium channel blocker, dimethocaine which has a relatively high affinity for the dopamine transporter fully generalized to the cocaine stimulus in both groups of rats, while procaine which has a low affinity for the dopamine transporters only partially generalized to the cocaine-training stimulus in both groups of rats 5. Finally, lidocaine, which has negligible affinity for the dopamine transporter, did not generalize to the cocaine-training stimulus in either group of rats. The findings suggest similarities as well as subtle, but important, differences between the discriminative stimulus effects of cocaine and the dopamine uptake inhibitors, GBR-12909 and GBR12935.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11371002     DOI: 10.1016/s0278-5846(00)00180-9

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  5 in total

1.  Neural response to lidocaine in healthy subjects.

Authors:  Bryon Adinoff; Michael D Devous; Donald C Cooper; Susan E Best; Thomas S Harris; Mark J Williams
Journal:  Psychiatry Res       Date:  2009-06-28       Impact factor: 3.222

2.  Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats.

Authors:  Harmony I Risca; Lisa E Baker
Journal:  Psychopharmacology (Berl)       Date:  2018-12-15       Impact factor: 4.530

3.  Preclinical evaluation of the abuse potential of the analgesic bicifadine.

Authors:  Katherine L Nicholson; Robert L Balster; Krystyna Golembiowska; Magdalena Kowalska; Joseph P Tizzano; Phil Skolnick; Anthony S Basile
Journal:  J Pharmacol Exp Ther       Date:  2009-04-08       Impact factor: 4.030

4.  Dopamine β-hydroxylase inhibitors enhance the discriminative stimulus effects of cocaine in rats.

Authors:  Daniel F Manvich; Lauren M DePoy; David Weinshenker
Journal:  J Pharmacol Exp Ther       Date:  2013-09-25       Impact factor: 4.030

Review 5.  Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendations.

Authors:  Sally L Huskinson; Jennifer E Naylor; James K Rowlett; Kevin B Freeman
Journal:  Neuropharmacology       Date:  2014-03-22       Impact factor: 5.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.